GeneDx Holdings Corp. (WGS) Stock Overview
Explore GeneDx Holdings Corp.’s financial performance, market position, analyst ratings, and future outlook.
GeneDx Holdings Corp. (WGS)
Key Financials
Key Financials
Market Cap
2.8B
P/E Ratio
-26.31
EPS (TTM)
$0.36
ROE
-0.39%
WGS Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of GeneDx Holdings Corp. (NASDAQ: WGS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, GeneDx Holdings Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of WGS on the NASDAQ shows an RSI of 70.35, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $132.80 for the NASDAQ listing.
Key metrics behind GeneDx Holdings Corp.'s NASDAQ-traded stock include a P/E ratio of -26.31 and a market capitalization of 2.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of WGS on the NASDAQ.